Home › Trial NCT06713798
Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures
- Trial IDNCT06713798
- StatusWithdrawn
- PhasePhase 2
- Study typeInterventional
- SponsorGustave Roussy, Cancer Campus, Grand Paris
- Enrollment—
- Start date2025-01-30
- ConditionsMetastatic Cancer Lung · Advanced Lung Cancer · CBNPC Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.